XML 58 R26.htm IDEA: XBRL DOCUMENT v2.4.0.6
Financial Instruments Measured at Fair Value (Tables)
3 Months Ended
Mar. 31, 2012
Financial Instruments Measured at Fair Value [Abstract]  
Schedule of Fair Value Assets and Liabilities Measured on Recurring Basis Table [Text Block]
The following table presents assets (liabilities) measured at fair value on a recurring basis at March 31, 2012:

 
 
Level 1
 
Level 2
 
Level 3
 
Total
Cash equivalents
 
$
381,220

 
$

 
$

 
$
381,220

Available-for-sale securities
 
54,216

 

 

 
54,216

Interest rate swaps
 

 
1,537

 

 
1,537

Foreign exchange contracts
 

 
(803
)
 

 
(803
)
Contingent consideration
 

 

 
(15,031
)
 
(15,031
)
 
 
$
435,436

 
$
734

 
$
(15,031
)
 
$
421,139


The following table presents assets (liabilities) measured at fair value on a recurring basis at December 31, 2011:

 
 
Level 1
 
Level 2
 
Level 3
 
Total
Available-for-sale securities
 
$
45,421

 
$

 
$

 
$
45,421

Interest rate swaps
 

 
(3,009
)
 

 
(3,009
)
Foreign exchange contracts
 

 
(649
)
 

 
(649
)
 
 
$
45,421

 
$
(3,658
)
 
$

 
$
41,763

Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]
The following table summarizes the Level 3 activity for the first quarter of 2012:
Balance as of December 31, 2011
$

Fair value of initial contingent consideration
(14,850
)
Change in fair value of contingent consideration included in earnings
(181
)
Balance as of March 31, 2012
$
(15,031
)
Available-for-sale Securities [Text Block]
The fair value of the company's available-for-sale securities is as follows:

 
 
March 31, 2012
 
December 31, 2011
  
 
Marubun
 
WPG
 
Marubun
 
WPG
Cost basis
 
$
10,016

 
$
10,798

 
$
10,016

 
$
10,798

Unrealized holding gain (loss)
 
1,900

 
31,502

 
(371
)
 
24,978

Fair value
 
$
11,916

 
$
42,300

 
$
9,645

 
$
35,776

Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Text Block]
The fair values of derivative instruments in the consolidated balance sheets are as follows:

 
 
Asset (Liability) Derivatives
  
 
  
 
Fair Value
  
 
Balance Sheet
Location
 
March 31,
2012
 
December 31,
2011
Derivative instruments designated as hedges:
 
 
 
 
 
 
Interest rate swaps designated as cash flow hedges
 
Other assets
 
$
1,537

 
$

Interest rate swaps designated as cash flow hedges
 
Other liabilities
 

 
(3,009)
Foreign exchange contracts designated as cash flow hedges
 
Other current assets
 
122

 
73

Foreign exchange contracts designated as cash flow hedges
 
Accrued expenses
 
(291
)
 
(641
)
Total derivative instruments designated as hedging instruments
 
 
 
1,368

 
(3,577
)
Derivative instruments not designated as hedges:
 
 
 
 

 
 

Foreign exchange contracts
 
Other current assets
 
1,027

 
2,218

Foreign exchange contracts
 
Accrued expenses
 
(1,661
)
 
(2,299
)
Total derivative instruments not designated as hedging instruments
 
 
 
(634
)
 
(81
)
Total
 
 
 
$
734

 
$
(3,658
)
Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance [Text Block]
The effect of derivative instruments on the consolidated statement of operations is as follows:

 
 
Gain (Loss)  Recognized in Income
  
 
Quarter Ended
  
 
March 31,
2012
 
April 2,
2011
Derivative instruments not designated as hedges:
 
 
 
 
Foreign exchange contracts (a)
 
$
(793
)
 
$
(1,703
)
Total
 
$
(793
)
 
$
(1,703
)

 
 
Cash Flow Hedges
 
 
Interest Rate Swaps (b)
 
Foreign Exchange Contracts (c)
Quarter Ended March 31, 2012
 
 
 
 
Effective portion:
 
 
 
 
  Gain (loss) recognized in other comprehensive income
 
$
4,546

 
$
440

  Gain (loss) reclassified into income
 
$

 
$
(41
)
Ineffective portion:
 
 
 
 
  Gain (loss) recognized in income
 
$

 
$

 
 
 
 
 
Quarter Ended April 2, 2011
 
 
 
 
Effective portion:
 
 
 
 
  Gain (loss) recognized in other comprehensive income
 
$

 
$
500

  Gain (loss) reclassified into income
 
$

 
$
(44
)
Ineffective portion:
 
 
 
 
  Gain (loss) recognized in income
 
$

 
$



(a)
The amount of gain (loss) recognized in income on derivatives is recorded in "Cost of sales" in the company's consolidated statements of operations.
(b)
Both the effective and ineffective portions of any gain (loss) reclassified or recognized in income are recorded in "Interest and other financing expense, net" in the company's consolidated statements of operations.
(c)
Both the effective and ineffective portions of any gain (loss) reclassified or recognized in income are recorded in "Cost of sales" in the company's consolidated statements of operations.